
While the Consumer Protection Act offers robust protection against defective products, ‘the rapid advancement of neurotechnology presents unprecedented challenges to this framework’, writes Lambert, founder and head of the Centre for Neurotechnology & Law. He explores three areas where the Act’s limitations become ‘starkly apparent’, for example, ‘the inherent plasticity of the brain and the consequently insidious, long-term risks of neurotechnology use, especially in children’.
What is a ‘defect’? Due to incredible advances in neurotechnology, key legal definitions may need an update. Lambert explains the tech that exists or is on its way, and the gaps in the law arising as a result.
He writes: ‘The accumulation of micro-injuries from invasive neurostimulation may not present symptoms until significant damage occurs. The same is true of subtle neurotransmitter imbalances which may not present obvious symptoms initially, but can lead to mood disorders or cognitive dysfunction over time.’